Hills Bank & Trust CO Astrazeneca PLC Transaction History

Hills Bank & Trust CO

$1.26 Billion
Q3 2024

A detailed history of Hills Bank & Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Hills Bank & Trust CO holds 1,540 shares of AZN stock, worth $115,838. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,540

Previous 1,540 -0.0%

Holding current value

$115,838

Previous $120,000 0.83%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$66.81 - $80.83 $10,622 - $12,851	-159 Reduced 9.36%	1,540 $120,000
Q4 2023 Feb 07, 2024	SELL	$61.89 - $69.28 $3,280 - $3,671	-53 Reduced 3.03%	1,699 $114,000
Q3 2023 Oct 26, 2023	SELL	$64.85 - $71.7 $1,621 - $1,792	-25 Reduced 1.41%	1,752 $118,000
Q2 2023 Jul 21, 2023	SELL	$69.91 - $75.81 $31,109 - $33,735	-445 Reduced 20.03%	1,777 $127,000
Q1 2023 Apr 17, 2023	SELL	$63.15 - $71.6 $46,541 - $52,769	-737 Reduced 24.91%	2,222 $154,000
Q4 2022 Feb 06, 2023	SELL	$54.21 - $70.44 $38,976 - $50,646	-719 Reduced 19.55%	2,959 $201,000
Q3 2022 Nov 03, 2022	SELL	$53.02 - $135.75 $47,718 - $122,175	-900 Reduced 19.66%	3,678 $202,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $91,853 - $110,267	-1,550 Reduced 25.29%	4,578 $303,000
Q1 2022 Aug 16, 2022	SELL	$55.72 - $67.12 $2.56 Million - $3.08 Million	-45,921 Reduced 88.23%	6,128 $407,000
Q1 2022 Apr 29, 2022	BUY	$55.72 - $67.12 $2.4 Million - $2.89 Million	43,081 Added 480.39%	52,049 $3.41 Million
Q4 2021 Feb 04, 2022	SELL	$54.02 - $63.83 $3,295 - $3,893	-61 Reduced 0.68%	8,968 $522,000
Q3 2021 Oct 27, 2021	BUY	$55.56 - $60.79 $501,651 - $548,872	9,029 New	9,029 $542,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hills Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hills Bank & Trust CO with notifications on news.

Account

Hills Bank & Trust CO Astrazeneca PLC Transaction History